In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumor
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 2 (1) , 43-47
- https://doi.org/10.1007/bf00253104
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1978
- Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin DZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Cystostatic efficacy of DNA-complexes of adriamycin, daunomycin, and actinomycin DZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Potentiation of actinomycin D or adriamycin antitumor activity with DNA.1976
- UPTAKE OF ADRIAMYCIN AND DAUNOMYCIN IN L1210 AND HUMAN LEUKEMIA-CELLS - COMPARATIVE-STUDY1976
- Comparison of adriamycin with DNA-adriamycin complex in chemotherapy of experimental tumors and metastasesPublished by Elsevier ,1975
- Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo.1975
- Experimental leukemia chemotherapy with a “lysosomotropic” adriamycin-DNA complexPublished by Elsevier ,1974
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956